SQA
ONCE

Simon Quick Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Simon Quick Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,500
Closed -$75K – 397
2016
Q4 		$75K Buy
+1,500
New +$80.4K 0.06% 137

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return

Simon Quick Advisors's ONCE Position: Q1 2017 in Review

Simon Quick Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2017, closing a stake of 1,500 shares — an estimated $75K sold.

Simon Quick Advisors first reported a position in ONCE in Q4 2016 and held it in 1 quarter. The position peaked at $75K in Q4 2016. 122 funds tracked by Wall St. Rank hold ONCE as of Q1 2017.

  • Simon Quick Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Simon Quick Advisors sold 1,500 Spark Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $75K.
  • Simon Quick Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2016 and held it in 1 quarter.
  • Simon Quick Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $75K in Q4 2016.
  • 122 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2017.

Based on Simon Quick Advisors's 13F filing for Q1 2017, filed 11 May 2017.